JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...

After 50 years of life, people who were born preterm had lower odds for some cardiovascular outcomes and similar odds for ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press ...

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

High job strain was significantly associated with sleep disturbances over a follow-up of nearly 10 years, highlighting the ...

Factors such as non-Hispanic Black race and all-cause mortality within 90 days after tuberculosis, or TB, diagnosis, as well ...

The CDC has awarded Weill Cornell Medicine a 5-year, $2.3 million grant to advance equitable access to care for young ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

According to published results, patients with dysplasia with a trochlear bump and patella alta may be at increased risk for ...